Using artificial intelligence to evaluate pulmonary hypertension
Official title: Artificial Intelligence-Assisted Evaluation of Pulmonary Hypertension
Run by Chinese Pulmonary Vascular Disease Research Group · NCT05566002 · Data updated 2026-11-12
This study is testing if using artificial intelligence with different medical tests can help doctors find pulmonary hypertension earlier and more accurately in patients.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 2000 (estimated) |
| Sponsor | Chinese Pulmonary Vascular Disease Research Group Academic / other |
| Locations | 1 site (Beijing, Beijing Municipality) |
| Status | Recruiting |
| Started | June 1, 2022 |
| Main results expected | December 31, 2028 |
| Study ends | December 31, 2028 |
| Registry record updated | October 22, 2026 |
| Trial ID | NCT05566002 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are adults aged 18 and older who have undergone the necessary routine examinations and right heart catheterization at Fuwai Hospital.
✕Probably not a fit
Patients who have not undergone right heart catheterization or whose examination results are of insufficient quality will not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This study focuses on patients with pulmonary hypertension (PH) who undergo right heart catheterization at Fuwai Hospital. It aims to combine various clinical data, including results from chest X-rays, electrocardiograms, and echocardiograms, with artificial intelligence techniques to enhance the screening and diagnosis of PH. By developing AI-assisted programs, the study seeks to improve diagnostic accuracy compared to traditional methods. The ultimate goal is to facilitate earlier detection of PH, which is crucial for effective treatment.
Why it matters
Potential benefit: If successful, this approach could lead to earlier and more accurate diagnoses of pulmonary hypertension, improving patient outcomes.
How similar studies have gone: While the use of artificial intelligence in medical diagnostics is a growing field, this specific application to pulmonary hypertension is relatively novel and has not been extensively tested in prior studies.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Age ≥18 years old * Patients previously received chest X-ray, electrocardiography, echocardiography, other routine examinations, and RHC at the Fuwai Hospital, CAMS \& PUMC, Beijing, China Exclusion Criteria: * Patients without RHC * The quality of routine examinations and RHC cannot meet the requirement for further analysis * Severe loss of results of routine examinations (chest X-ray, electrocardiography, echocardiography, etc.)
Where it's running
-
Fuwai Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College
Beijing, Beijing Municipality, China Recruiting
Study contacts
- Principal investigator: Zhihong Liu, MD, PhD — Fuwai Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College
- Study coordinator: Zhihong Liu, MD, PhD
- Email: zhihongliufuwai@163.com
- Phone: 13269276067
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Rutgers Genetics of Pulmonary Hypertension
This online project will try to see if genetic differences affect the risk of pulmonary hypertension in U.S. adults, and anyone 18 or older can join whether or not they have PH.
-
Quality control of right heart catheterization for pulmonary vascular diseases in China
This study looks at the quality of right heart catheterization procedures for people with suspected pulmonary hypertension in China to see how well they are being done and what outcomes patients experience.
-
129Xe MRI to monitor sotatercept treatment in pulmonary arterial hypertension
This will test whether hyperpolarized 129Xe MRI scans can noninvasively track lung blood-vessel improvement in adults with pulmonary arterial hypertension treated with sotatercept.
-
Using Xenon MRI to study pulmonary hypertension
This study is testing if a special type of MRI can help understand how lung changes in people with pulmonary arterial hypertension affect their breathing and overall health.
-
Registry and biorepository for pulmonary hypertension patients
This study is setting up a collection of health information and blood samples from people with pulmonary hypertension to help researchers learn more about the disease and improve treatments.
-
Treatment for pulmonary arterial hypertension using a new device
This study is testing a new device to see if it can safely help people with pulmonary hypertension and right heart problems feel better.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.